此内容来自:xinyabo体育

生命科学基金在2022年继续挣扎

大多数人在第一季度被两位数下降。

Life sciences hedge funds picked up in the first quarter where they left off last year.And that’s not a good thing.Many of them not only lost money for the three-month period, they suffered another round of double-digit losses following last year’s disastrous declines.The life sciences hedge funds are victims of

继续阅读,现在订阅高级新闻。已经是订户了吗?登录